The BCG vaccine remodels the human brain’s immune environment via trained immunity. Tracking older adults over one year, researchers demonstrated that BCG enhances central nervous system immune cell responsiveness and lowers amyloid-beta levels in the cerebrospinal fluid of healthy individuals, offering an early preventative pathway against Alzheimer’s disease.
